跳至主要内容
临床试验/IRCT20090117001556N156
IRCT20090117001556N156招募中2 期

Metformin (antidiabetic drug) as an adjuvant therapy in the treatment of irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 11 years(—)
性别
All

入选标准

  • Age between 5-11 years
  • Diagnosis of autism spectrum disorder based on DSM-V
  • Patients who have specific behavioral problems such as aggression, hyperactivity, unusual, and stereotyped behaviors

排除标准

  • An active medical disease
  • Diagnosis of another psychological disorder in DSM
  • History of previous sensitivity and intolerance to metformin
  • History of seizure and liver disorders
  • Taking antipsychotic drugs such as Risperidone before entering the study

研究者

相似试验

Metformin as an adjuvant therapy for autism | 临床试验